BioCentury | Jan 18, 2020
Product Development

Mapping the path to gene therapy 2.0

...is changing its organizational structure to focus on finding a path forward for the therapy. Gene Biotherapeutics Inc....
BioCentury | Jan 7, 2016
Translation in Brief

New beginnings

...pharma industry another approach to tackle heart disease. A growing number of companies - including Taxus Cardium...
BioCentury | Jul 23, 2015
Tools & Techniques

Gene therapy's coming of age

...Ear; Heart; Liver Phase III Ascend Biopharmaceuticals Ltd.; GenVec Inc. (NASDAQ:GNVC); Novartis AG (NYSE:NVS; SIX:NOVN); Taxus Cardium...
...MultiVir Inc. , Novartis, PNP Therapeutics Inc. , Shenzhen SiBiono GeneTech Co. Ltd. , Taxus Cardium...
BioCentury | May 25, 2015
Company News

Taxus Cardium, Shenzhen Qianhai Taxus Insdustry Capital Management deal

...Taxus Cardium granted Shenzhen the first right to negotiate for an exclusive license to develop and...
...Shenzhen will purchase 15% of Taxus’ Angionetics Inc. subsidiary for $3 million by May 30. Taxus Cardium...
BioCentury | May 4, 2015
Company News

Taxus Cardium, Dr. Reddy’s Laboratories Ltd. deal

...CAD). Dr. Reddy’s declined to disclose additional details, and Taxus did not respond to inquiries. Taxus Cardium...
BioCentury | Apr 7, 2015
Company News

Management tracks

...play La Jolla Pharmaceutical Co. (NASDAQ:LJPC) hired Dennis Mulroy as CFO. He was CFO at Taxus Cardium...
BioCentury | Feb 16, 2015
Clinical News

Generx cardionovo alferminogene tadenovec: Interim Phase III data

...patients treated with Generx experienced an improvement in RPDS. The trial is enrolling 100 patients. Taxus Cardium...
BioCentury | Jan 26, 2015
Company News

Taxus Cardium board of directors update

...Taxus Cardium Pharmaceuticals Group Inc. (OTCQB:CRXM), San Diego, Calif. Business: Cardiovascular Appointed: John Wallace, president of...
BioCentury | Apr 7, 2014
Finance

1Q Stock Wrap-Up: Small but mighty

...vedolizumab Moderate to severe Crohn's disease PDUFA date 6/18/14 Taxus Cardium Pharmaceuticals Group Inc. (OTCQB:CRXM) (formerly Cardium...
BioCentury | Mar 24, 2014
Company News

Shanxi Taxus, Taxus Cardium deal

...Cardium Therapeutics Inc. changed its name to Taxus Cardium and partnered with Shanxi Taxus to promote each...
...apply "commercially reasonable efforts" to assist Taxus Cardium to develop and refine a plan to commercialize Taxus Cardium's...
...Taxus Cardium received an initial tranche of $500,000 through the sale of 714,286 shares at $0.70. Taxus Cardium...
Items per page:
1 - 10 of 87
BioCentury | Jan 18, 2020
Product Development

Mapping the path to gene therapy 2.0

...is changing its organizational structure to focus on finding a path forward for the therapy. Gene Biotherapeutics Inc....
BioCentury | Jan 7, 2016
Translation in Brief

New beginnings

...pharma industry another approach to tackle heart disease. A growing number of companies - including Taxus Cardium...
BioCentury | Jul 23, 2015
Tools & Techniques

Gene therapy's coming of age

...Ear; Heart; Liver Phase III Ascend Biopharmaceuticals Ltd.; GenVec Inc. (NASDAQ:GNVC); Novartis AG (NYSE:NVS; SIX:NOVN); Taxus Cardium...
...MultiVir Inc. , Novartis, PNP Therapeutics Inc. , Shenzhen SiBiono GeneTech Co. Ltd. , Taxus Cardium...
BioCentury | May 25, 2015
Company News

Taxus Cardium, Shenzhen Qianhai Taxus Insdustry Capital Management deal

...Taxus Cardium granted Shenzhen the first right to negotiate for an exclusive license to develop and...
...Shenzhen will purchase 15% of Taxus’ Angionetics Inc. subsidiary for $3 million by May 30. Taxus Cardium...
BioCentury | May 4, 2015
Company News

Taxus Cardium, Dr. Reddy’s Laboratories Ltd. deal

...CAD). Dr. Reddy’s declined to disclose additional details, and Taxus did not respond to inquiries. Taxus Cardium...
BioCentury | Apr 7, 2015
Company News

Management tracks

...play La Jolla Pharmaceutical Co. (NASDAQ:LJPC) hired Dennis Mulroy as CFO. He was CFO at Taxus Cardium...
BioCentury | Feb 16, 2015
Clinical News

Generx cardionovo alferminogene tadenovec: Interim Phase III data

...patients treated with Generx experienced an improvement in RPDS. The trial is enrolling 100 patients. Taxus Cardium...
BioCentury | Jan 26, 2015
Company News

Taxus Cardium board of directors update

...Taxus Cardium Pharmaceuticals Group Inc. (OTCQB:CRXM), San Diego, Calif. Business: Cardiovascular Appointed: John Wallace, president of...
BioCentury | Apr 7, 2014
Finance

1Q Stock Wrap-Up: Small but mighty

...vedolizumab Moderate to severe Crohn's disease PDUFA date 6/18/14 Taxus Cardium Pharmaceuticals Group Inc. (OTCQB:CRXM) (formerly Cardium...
BioCentury | Mar 24, 2014
Company News

Shanxi Taxus, Taxus Cardium deal

...Cardium Therapeutics Inc. changed its name to Taxus Cardium and partnered with Shanxi Taxus to promote each...
...apply "commercially reasonable efforts" to assist Taxus Cardium to develop and refine a plan to commercialize Taxus Cardium's...
...Taxus Cardium received an initial tranche of $500,000 through the sale of 714,286 shares at $0.70. Taxus Cardium...
Items per page:
1 - 10 of 87